In vitro effects from atorvastatin and metformin on cell proliferation induced by dyslipidemic contexts in benign prostatic hyperplasia
Benign prostatic hyperplasia (BPH) is characterized by uncontrolled proliferation of mainly stromal elements, arise from a conjunction of multiple physiopathogenic factors. Among them, the metabolic syndrome components are strongly correlated to the risk of suffering from BPH and its aggressiveness,...
Guardado en:
| Autores principales: | Reinarz Torrado, KF, Martinez Piñerez, DE, Roldán Gallardo, FF, López Seoane, M, Maldonado, CA, Quintar , AA |
|---|---|
| Formato: | Artículo revista |
| Publicado: |
Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología
2022
|
| Materias: | |
| Acceso en línea: | https://revistas.unc.edu.ar/index.php/med/article/view/38977 |
| Aporte de: |
Ejemplares similares
-
New therapeutic approach in fatty liver disease associated with metabolic dysfunction
por: Castillo, TA, et al.
Publicado: (2021) -
Pharmacological analysis of metabolic syndrome appraised by oxidative stress markers
por: Castillo, TA, et al.
Publicado: (2019) -
Obtaining and characterizing extracellular vesicles from human prostate stromal cells derived from patients with benign prostatic hyperplasia
por: Roldán Gallardo, FF, et al.
Publicado: (2022) -
Efecto de metformina sobre la proliferación y liberación de vesículas extracelulares en células estromales de pacientes con hiperplasia prostática benigna
por: Romero Humacata , JF, et al.
Publicado: (2024) -
Estudio teórico de fotocatalizadores basados en BiOX
por: Fuente, Silvia, et al.
Publicado: (2022)